One of the pioneers and leaders of the immunotherapy revolution in clinical oncology. Dr. Antonia has been a principal investigator on many of the most important clinical trials of checkpoint inhibitors in lung cancer. Dr. Antonia most recently was Chairman of the Department of Thoracic Oncology at Moffitt Cancer Center. He serves on the clinical development advisory boards of several major pharmaceutical companies.

Recognized leader in the use of gene transfer to augment the immune response to human tumors using vaccines and adoptive transfer of genetically modified T cells. Dr. Brenner has coauthored more than three hundred publications that have been cited thousands of times. Dr. Brenner has previously served as President of both the International Society for Cell Therapy (ISCT) and American Society for Gene Therapy (ASGT).

Senior Member and Professor in the Departments of Immunology and Thoracic Oncology at the Moffitt Cancer Center. Dr. Beg has been at the forefront of immunology research with numerous publications to his credit. Dr. Beg leads the immunology group at Moffitt’s Lung Cancer Center of Excellence and actively serves on NIH study sections and journal editorial boards.

Associate Professor Department of Melanoma Medical Oncology. Dr. Diab is leading multiple clinical trials involving novel immune modulator agents and has co-authored over thirty scientific publications and abstracts. Reviewer for the Journal of Immunotherapy and the Journal of the American Society of Hematology. In addition, he is leading a program for Interventional Immunotherapy that was established to develop intratumoral therapies designed to improve clinical outcomes.

World-renowned virologist and vaccinologist. Dr. Monath has developed innovative vaccines, including Ebola Zaire, dengue, and C. difficile, many of which are now licensed and commercialized. He was a partner at Kleiner Perkins and has been CSO and CMO of several biotechnology companies. He has served in leading roles at the CDC and USAMRIID. He is a past president of the American Society of Tropical Medicine and Hygiene, and an elected Fellow of the Society.

Medical Oncologist, Section Head, Gynecologic Medical Oncology at Icahn School of Medicine at Mount Sinai specializing in immunotherapies and treatment of gynecologic cancers and other solid tumors with expertise using genetically engineered oncolytic viruses to stimulate the immune system. Dr. Zamarin has received awards including 2014 Bladder Cancer Awareness Network Young Investigator and 2013 Conquer Cancer Foundation ASCO Young Investigator.